get the top three things to know in women's health + wellness, every weekday:

Less Than 1 Percent of Insurers Have Guidance for Postpartum Depression Drug

What: Stateline’s Nada Hassanein investigates coverage for the first postpartum depression drug and finds that only 17 insurers–less than 1 percent of the 1,000 insurance companies in the country–have published coverage guidance. The new medication, Zurzuvae, recently hit the market and costs $16,000.

Why it matters: As Hassanein reports, Medicaid covers 41% of births nationwide, and many state Medicaid agencies haven’t yet said if they’ll cover the medication. Which means many women who may need this drug can’t get it yet.

Source: Stateline

More News Snippets
OBGYN Pain Goes Beyond IUDs

Sharing the stories of women who have had fibroids removed without pain medication or endometriosis symptoms ignored for years.

The Birth Rate Fallacy

Experts explaining that the global drop in fertility rates is partly a product of women having children later in life.

Could Ozempic Prevent Fibroids?

Women with type 2 diabetes who got a GLP-1 medication were less likely to develop new fibroids than women who just took metformin, a diabetes medication.

Alcohol’s Lies (and Breast Cancer)

A deep dive on drinking and examining why people reacted far more swiftly to the news that smoking causes cancer than they have for alcohol—especially breast cancer.

Another Mother Dead Thanks to Abortion Bans

Josseli Barnica was excited to be pregnant with her second child but suffered a miscarriage at 17 weeks. Instead of helping the miscarriage progress, doctors let her suffer for 40 hours because her fetus still had a heartbeat.